153
Views
3
CrossRef citations to date
0
Altmetric
Articles

Serum vitamin D deficiency in subjects with severe acquired brain injury and relationship with functional severity

, , &
Pages 1817-1823 | Received 17 May 2018, Accepted 14 Oct 2018, Published online: 19 Oct 2018

References

  • Herrmann M, Sullivan DR, Veillard AS, McCorquodale T, Straub IR, Scott R, Laakso M, Topliss D, Jenkins AJ, Blankenberg S, et al. FIELD study investigators. Serum 25-Hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care. 2015 Mar;38(3):521–28.
  • Welles CC, Whooley MA, Karumanchi SA, Hod T, Thadhani R, Berg AH, Ix JH, Mukamal KJ. Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol. 2014 Jun 1;179(11):1279–87. doi:10.1093/aje/kwu059.
  • Leu Agelii M, Lehtinen-Jacks S, Zetterberg H, Sundh V, Björkelund C, Lissner L. Low vitamin D status in relation to cardiovascular disease and mortality in Swedish women - Effect of extended follow-up. Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1143–51. doi:10.1016/j.numecd.2017.10.013. Epub 2017 Oct 25.
  • Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int. 2011 Mar;22(3):859–71. doi:10.1007/s00198-010-1407-y.
  • Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P. Vitamin D as a protective factor in multiple sclerosis. Neurology. 2012;79:2140–45.doi:10.1212/WNL.0b013e3182698d8d.
  • Niino M, Sato S, Fukazawa T, Masaki K, Miyazaki Y, Matsuse D, Yamasaki R, Takahashi E, Kikuchi S, Kira J. Decreased serum vitamin D levels in Japanese patients with multiple sclerosis. J Neuroimmunol. 2015 Feb 15;279:40–45. doi:10.1016/j.jneuroim.2015.01.007.
  • Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Goltzman D, Leong A, Greenwood CM, Thanassoulis G, Richards JB. Correction: vitamin D and risk of multiple sclerosis: a mendelian randomization study. PLoS Med. 2016 Mar 2;13(3):e1001981. doi:10.1371/journal.pmed.1001981.
  • Evatt ML. Parkinson disease: low vitamin D and Parkinson disease-a causal conundrum. Nat Rev Neurol. 2014 Jan;10(1):8–9. doi:10.1038/nrneurol.2013.252.
  • Wang L, Evatt ML, Maldonado LG, Perry WR, Ritchie JC, Beecham GW, Martin ER, Haines JL, Pericak-Vance MA, Vance JM, et al. Vitamin D from different sources is inversely associated with Parkinson disease. Mov Disord. 2015 Apr;30(4):560–66. doi:10.1002/mds.26117.
  • Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR, Kuller LH, Langa KM, et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology. 2014;83:920–28. doi:10.1212/WNL.0000000000000755.
  • Teagarden DL, Meador KJ, Loring DW. Low vitamin D levels are common in patients with epilepsy. Epilepsy Res. 2014;108(8):1352–56. doi:10.1016/j.eplepsyres.2014.06.008.
  • Gueye Y, Marqueste T, Maurel F, Khrestchatisky M, Decherchi P, Feron F. Cholecalciferol (vitamin D₃) improves functional recovery when delivered during the acute phase after a spinal cord trauma. J Steroid Biochem Mol Biol. 2015 Nov;154:23–31. doi:10.1016/j.jsbmb.2015.06.007.
  • Turetsky A, Goddeau RP Jr, Henninger N. Low serum vitamin D is independently associated with larger lesion volumes after ischemic stroke. J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1555–63. doi:10.1016/j.jstrokecerebrovasdis.2015.03.051.
  • Schneider AL, Lutsey PL, Selvin E, Mosley TH, Sharrett AR, Carson KA, Post WS, Pankow JS, Folsom AR, Gottesman RF, et al. vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Neurol. 2015 Aug;22(8):1220–27. doi:10.1111/ene.12731.
  • Lv WS, Zhao WJ, Gong SL, Fang DD, Wang B, Fu ZJ, Yan SL, Wang YG. Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis. J Endocrinol Invest. 2015 May;38(5):513–18. doi:10.1007/s40618-014-0210-6.
  • Santos RKF, Brandão-Lima PN, Tete RMDD, Freire ARS, Pires LV. Vitamin D ratio and glycaemic control in individuals with type 2 diabetes mellitus: A systematic review. Diabetes Metab Res Rev. 2018 Mar;34(3):e2969. doi:10.1002/dmrr.v34.3.
  • Toman E, Bishop JR, Davies DJ, Su Z, Criseno S, Mason A, Toogood AA, Belli A. Vitamin D deficiency in traumatic brain injury and its relationship with severity of injury and quality of life: a prospective, observational study. J Neurotrauma. 2017 Apr 1;34(7):1448–56. doi:10.1089/neu.2016.4494.
  • Zampolini M, Corea F, Avesani R, Boldrini P, De Tanti A, Di Stefano MG, Formisano R, Lamberti G, Lombardi F, Mazzucchi A, et al. Rehabilitation of acquired brain injuries: a multicentric prospective survey. Eur J Phys Rehabil Med. 2013;49(3):365–72.
  • Laver K, Lannin NA, Bragge P, Hunter P, Holland AE, Tavender E, O’Connor D, Khan F, Teasell R, Gruen R. Organising health care services for people with an acquired brain injury: an overview of systematic reviews and randomised controlled trials. BMC Health Serv Res. 2014 Sep 17;14:397. doi:10.1186/1472-6963-14-397.
  • Intiso D, Di Rienzo F, Fontana A, Tolfa M, Bartolo M, Copetti M. Functional outcome of critical illness polyneuropathy in patients affected by severe brain injury. Eur J Phys Rehabil Med. 2017 Dec;53(6):910–19. doi:10.23736/S1973-9087.17.04595-6.
  • Portaccio E, Morrocchesi A, Romoli AM, Hakiki B, Taglioli MP, Lippi E, Di Renzone M, Grippo A, Macchi C. Score on coma recovery scale-revised at admission predicts outcome at discharge in intensive rehabilitation after severe brain injury. Brain Inj. 2018 Feb 26;32(6):1–5. doi:10.1080/02699052.2017.1382717.
  • Gouvier WD, Blanton PD, LaPorte KK, Nepomuceno C. Reliability and validity of the disability rating scale and the levels of cognitive functioning scale in monitoring recovery from severe head injury. Arch Phys Med Rehabil. 1987 Feb;68(2):94–97.
  • Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975 Mar 1;1(7905):480–84.
  • The Level of Cognitive Functioning Scale. The center for outcome measurement in brain injury. [ accessed 2018 May 17] http://www.tbims.org/combi/lcfs
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.doi:10.1210/jc.2011-0385.
  • Mpandzou G, Aït Ben Haddou E, Regragui W, Benomar A, Yahyaoui M. Vitamin D deficiency and its role in neurological conditions: A review. Rev Neurol (Paris). 2016 Feb;172(2):109–22. doi:10.1016/j.neurol.2015.11.005.
  • Thouvenot E, Orsini M, Daures JP, Camu W. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis. Eur J Neurol. 2015 Mar;22(3):564–69. doi:10.1111/ene.12617.
  • Annweiler C, Bartha R, Karras SN, Gautier J, Roche F, Beauchet O. Vitamin D and white matter abnormalities in older adults: a quantitative volumetric analysis of brain MRI. Exp Gerontol. 2015;63:41–47.doi:10.1016/j.exger.2015.01.049.
  • Majumdar V, Prabhakar P, Kulkarni GB, Christopher R. Vitamin D status, hypertension and ischemic stroke: a clinical perspective. J Hum Hypertens. 2015;29(11):1–6. doi:10.1038/jhh.2014.36.
  • Nie Z, Ji XC, Wang J, Zhang HX. Serum levels of 25-hydroxyvitamin D predicts infarct volume and mortality in ischemic stroke patients. J Neuroimmunol. 2017 Dec 15;313:41–45. doi:10.1016/j.jneuroim.2017.10.002. Epub 2017 Oct 5.
  • Daumas A, Daubail B, Legris N, Jacquin-Piques A, Sensenbrenner B, Denimal D, Lemaire-Ewing S, Duvillard L, Giroud M, Béjot Y. Association between admission serum 25-Hydroxyvitamin D levels and functional outcome of thrombolyzed stroke patients. J Stroke Cerebrovasc Dis. 2016 Apr;25(4):907–13. doi:10.1016/j.jstrokecerebrovasdis.2016.01.005.
  • Xu T, Zhong C, Xu T, Peng Y, Bu X, Chen CS, Wang J, Ju Z, Li Q, Geng D, et al. Serum 25-hydroxyvitamin D deficiency predicts long-term poor prognosis among ischemic stroke patients without hyperglycaemia. Clin Chim Acta. 2017 Aug;471:81–85. doi:10.1016/j.cca.2017.05.020.
  • Park KY, Chung PW, Kim YB, Moon HS, Suh BC, Won YS, Kim JM, Youn YC, Kwon OS. Serum vitamin D status as a predictor of prognosis in patients with acute ischemic stroke. Cerebrovasc Dis. 2015;40(1–2):73–80. doi:10.1159/000434691.
  • Zhang B, Wang Y, Zhong Y, Liao S, Lu Z. Serum 25-hydroxyvitamin D deficiency predicts poor outcome among acute ischemic stroke patients without hypertension. Neurochem Int. 2018 Sep;118:91–95. doi:10.1016/j.neuint.2018.05.001. Epub 2018 May 3.
  • Wei ZN, Kuang JG. Vitamin D deficiency in relation to the poor functional outcomes in nondiabetic patients with ischemic stroke. Biosci Rep. 2018 Mar 5;38(2):BSR20171509. doi:10.1042/BSR20171509.
  • Jamall OA, Feeney C, Zaw-Linn J, Malik A, Niemi ME, Tenorio-Jimenez C, Ham TE, Jilka SR, Jenkins PO, Scott G, et al. Prevalence and correlates of vitamin D deficiency in adults after traumatic brain injury. Clin Endocrinol (Oxf). 2016 Oct;85(4):636–44. doi:10.1111/cen.13045.
  • Kruit A, Zanen P. The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseases. Clin Biochem. 2016 May;49(7–8):534–37. doi:10.1016/j.clinbiochem.2016.01.002.
  • Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. N Engl J Med. 2009 Apr 30;360(18):1912–14. doi:10.1056/NEJMc0809996.
  • de Haan K, Groeneveld AB, de Geus HR, Egal M, Struijs A. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Crit Care. 2014 Dec 5;18(6):660. doi:10.1186/cc13712.
  • Minnich JE, Mann SL, Stock M, Stolzenbach KA, Mortell BM, Soderstrom KE, Bohn MC, Kozlowski DA. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury. Restor Neurol Neurosci. 2010;28(3):293–309. doi:10.3233/RNN-2010-0528.
  • Orme RP, Bhangal MS, Fricker RA. Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression 2013. PLoS One. 2013 Apr 23;8(4):e62040. doi:10.1371/journal.pone.0062040. Print 2013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.